Amgen Inc. (
) will begin trading ex-dividend on February 11, 2014. A cash
dividend payment of $0.61 per share is scheduled to be paid on
March 07, 2014. Shareholders who purchased AMGN stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 29.79% increase over the prior quarter.
The previous trading day's last sale of AMGN was $118.9,
representing a -4.47% decrease from the 52 week high of $124.46 and
a 43.39% increase over the 52 week low of $82.92.
AMGN is a part of the Health Care sector, which includes
companies such as Gilead Sciences, Inc. (
) and Biogen Idec Inc. (
). AMGN's current earnings per share, an indicator of a company's
profitability, is $6.65. Zacks Investment Research reports AMGN's
forecasted earnings growth in 2014 as 7.05%, compared to an
industry average of 8%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to AMGN through an Exchange
Traded Fund [ETF]?
The following ETF(s) have AMGN as a top-10 holding:
- iShares NASDAQ Biotechnology Index Fund (
- PowerShares Dynamic Pharmaceuticals (
- PowerShares Dynamic Biotech &Genome (
- Select Sector SPDR Fund - Health Care (
- Merrill Lynch Biotech HOLDRS (
The top-performing ETF of this group is PBE with an increase of
18.75% over the last 100 days. IBB has the highest percent
weighting of AMGN at 7.56%.